A large scale multicentre randomized, placebo-controlled subcutaneous house dust mite allergen immunotherapy (HDM SCIT) in allergic rhinitis: MITAR Study.
Suratannon N, Limsuwan T, Tantilipikorn P, Chatchatee P, Saengapaswiriya A, Boonpiyathad T, Thongngarm T, Roongpuvapaht B, Chantaphakul H, Kulalert P, Thanaviratananich S, Sangsupawanich P, Fooanant S, Manuyakorn W, Chusakul S, Piboonpochanun O, Apornpong T, Wongpiyabovorn J, Ruxrungtham K; MITAR Study Group.
Suratannon N, et al. Among authors: roongpuvapaht b.
Asian Pac J Allergy Immunol. 2024 Sep;42(3):233-245. doi: 10.12932/AP-221123-1735.
Asian Pac J Allergy Immunol. 2024.
PMID: 39417769
Free article.
Clinical Trial.